FDA Commissioner: Due to previous inaction by the FDA, combating the opioid crisis will 'be far more dramatic'

As the opioid epidemic continues to plague the nation, FDA Commissioner Scott Gottlieb, MD, says he regrets the agency's previous inaction in response to the crisis , reports USA Today.


Dr. Gottlieb revealed his take on the opioid epidemic at the National Academy of Medicine's annual meeting, which was held in Washington, D.C. last week. 

"We didn't get ahead of [the epidemic]. Nobody got ahead of it," Dr. Gottlieb said. "The type of action we need to take to finally address this crisis is going to be far more dramatic than we would have had to do had we made certain decisions years ago."

The FDA chief says he wants to avoid repeating the mistakes that were made at the agency in previous years, when the government failed to properly regulate opioids.

In response to the epidemic, Dr. Gottlieb is advocating for increased oversight of highly addictive opioids, stricter requirements for reformulated, injectable opioids and a cap on opioid prescriptions. 

More articles on opioids:
Nevada allocates more than $1M for state opioid epidemic initiative 
Bon Secours hospital cuts opioid use 80% with surgical recovery program 
Gov. John Kasich says Ohio might include drug distributors in opioid lawsuit after '60 Minutes' report

© Copyright ASC COMMUNICATIONS 2018. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months